title: Fasting plus tyrosine kinase inhibitors in cancer.
authors.affiliation: Department of Internal Medicine, University of Genoa, 16132 Genoa, Italy.
authors.forename: Irene
authors.initials: I
authors.lastname: Caffa
authors.affiliation: Longevity Institute, School of Gerontology, Department of Biological Sciences, University of Southern California, Los Angeles, CA 90089, USA.|IFOM, FIRC Institute of Molecular Oncology, 20139 Milan, Italy.
authors.forename: Valter D
authors.initials: VD
authors.lastname: Longo
authors.affiliation: Department of Internal Medicine, University of Genoa, 16132 Genoa, Italy.|IRCCS AOU San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, 16132 Genoa, Italy.
authors.forename: Alessio
authors.initials: A
authors.lastname: Nencioni
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004032:Diet; D005215:Fasting; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011878:Radiotherapy
chemical_list: D000970:Antineoplastic Agents; D011505:Protein-Tyrosine Kinases
keywords: MAPK signaling; cancer; fasting; molecularly targeted therapy; tyrosine kinase inhibitors